A pharmacokinetic substudy was conducted within a phase @ clinical trial that evaluated the efficacy and safety of two leuprolide acetate @-month depot formulations in children with central precocious puberty ( CPP ) , where the pharmacokinetics of leuprolide and the exposure-response relationship between leuprolide concentration and the probability of luteinizing hormone ( LH ) suppression were assessed .